Matsumoto Ryuji

Affiliation and department：

Research field (1)： Urology

Research keywords (1)：泌尿器科学

Research theme for competitive and other funds (1)：

2016 - 2018 To develop a new therapeutic method targeting AKR1C1 for urothelial carcinoma micrometastasis

Papers (128)：

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, et al. TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular cancer therapeutics. 2023
Hiroshi Kikuchi, Takashige Abe, Makito Miyake, Haruka Miyata, Ryuji Matsumoto, Takahiro Osawa, Nobutaka Nishimura, Kiyohide Fujimoto, Junichi Inokuchi, Takahiro Yoneyama, et al. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy. Japanese journal of clinical oncology. 2023
Hajime Miyata, Takashige Abe, Naoya Iwahara, Hiroshi Kikuchi, Hiroki Chiba, Ryuji Matsumoto, Takahiro Osawa, Hiroshi Tanaka, Ken Morita, Tomoko Mitsuhashi, et al. [A Case of Testicular Cancer with Solitary Iliac Bone Metastasis]. Hinyokika kiyo. Acta urologica Japonica. 2023. 69. 9. 259-264
Yoichiro Tohi, Ryou Ishikawa, Takuma Kato, Jimpei Miyakawa, Ryuji Matsumoto, Keiichiro Mori, Koji Mitsuzuka, Junichi Inokuchi, Masafumi Matsumura, Kenichiro Shiga, et al. Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort. Japanese journal of clinical oncology. 2023
Takashige Abe, Shuhei Yamada, Hiroshi Kikuchi, Ataru Sazawa, Hidenori Katano, Hidetaka Suzuki, Ichiro Takeuchi, Keita Minami, Ken Morita, Kunihiko Tsuchiya, et al. Impact of postoperative complications on long-term survival in bladder cancer patients. Japanese journal of clinical oncology. 2023

ｍore...

MISC (333)：

安部崇重, 宮田遥, 松本隆児, 大澤崇宏, 篠原信雄. 【バイプレーヤーズ!転移性癌治療における外科治療の役割,徹底解明】(Part 1)薬物治療が進歩した今,転移性癌の原発巣切除は勧められるか!? 転移性尿路上皮癌の原発巣切除は勧められるか?. 泌尿器外科. 2023. 36. 10. 1091-1095
土肥洋一郎, 加藤琢磨, 中村真樹, 松本隆児, 佐々木裕, 三塚浩二, 猪口淳一, 橋根勝義, 横溝晃, 原勲, et al. 早期前立腺癌に対する監視療法後の前立腺全摘の治療成績 PRIAS-JAPANデータ解析. 日本癌治療学会学術集会抄録集. 2023. 61回. IJCO-3
安部崇重, 今雅史, 樋口まどか, 堀田記世彦, 菊地央, 古御堂純, 岩原直也, 山田修平, 原田茂, 上條千太, et al. 増やそう未来の外科医!働き方改革における外科系教育泌尿器科手術に関するシミュレーショントレーニング当科での経験. 日本癌治療学会学術集会抄録集. 2023. 61回. SWS7-1
土肥洋一郎, 石川亮, 加藤琢磨, 宮川仁平, 松本隆児, 森啓一郎, 三塚浩二, 猪口淳一, 松村正文, 志賀健一郎, et al. 監視療法後の前立腺全摘におけるadverse pathologyの予測因子前向き観察研究の検討. 日本癌治療学会学術集会抄録集. 2023. 61回. O10-5
加藤琢磨, 松本隆児, 横溝晃, 土肥洋一郎, 木村高広, 久米春喜, 福原浩, 佐藤琢磨, 猪口淳一, 橋根勝義, et al. 監視療法の多施設共同前向き観察研究の長期成績 PRIAS-JAPAN. 日本癌治療学会学術集会抄録集. 2023. 61回. O14-6

ｍore...

Professional career (1)：

博士(医学) (北海道大学)

Awards (2)：

2019/03 - JUA-EAU Academic Exchange Programme
2015/03 - European association of Urology Best poster prize

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page